Ligand Pharmaceuticals
LGND
#4135
Rank
โ‚ฌ2.10 B
Marketcap
111,29ย โ‚ฌ
Share price
4.47%
Change (1 day)
107.79%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): 1,43ย โ‚ฌ

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,50ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,89ย โ‚ฌ a decrease over its 2021 EPS that were of 3,30ย โ‚ฌ.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,43ย โ‚ฌ-175.44%
2022-1,89ย โ‚ฌ-157.23%
20213,30ย โ‚ฌ-2571.43%
2020-0,13ย โ‚ฌ-100.46%
201929,23ย โ‚ฌ353.48%
20186,45ย โ‚ฌ1025%
20170,57ย โ‚ฌ-700%
2016-0,09549ย โ‚ฌ-100.87%
201511,04ย โ‚ฌ1859.32%
20140,56ย โ‚ฌ5.36%
20130,53ย โ‚ฌ8.0704505322479E+18%
20120,0000000000ย โ‚ฌ-100%
20110,47ย โ‚ฌ-194.23%
2010-0,50ย โ‚ฌ548.38%
2009-0,07658ย โ‚ฌ-98.7%
2008-5,90ย โ‚ฌ-136.52%
200716,16ย โ‚ฌ-787.8%
2006-2,35ย โ‚ฌ-14.58%
2005-2,75ย โ‚ฌ-21.31%
2004-3,49ย โ‚ฌ-55.15%
2003-7,79ย โ‚ฌ81.33%
2002-4,30ย โ‚ฌ2.74%
2001-4,18ย โ‚ฌ-45.93%
2000-7,73ย โ‚ฌ-3.18%
1999-7,99ย โ‚ฌ-45.52%
1998-14,66ย โ‚ฌ-3.97%
1997-15,27ย โ‚ฌ132.31%
1996-6,57ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
13,51ย โ‚ฌ 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,34ย โ‚ฌ-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
3,34ย โ‚ฌ 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
1,74ย โ‚ฌ 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
1,78ย โ‚ฌ 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
5,18ย โ‚ฌ 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
3,79ย โ‚ฌ 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
4,89ย โ‚ฌ 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
13,45ย โ‚ฌ 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA